Skip to content
Menu

Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $1

Benzinga Newsdesk 7 months ago

NewsPrice TargetAnalyst Ratings

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $2.75 to $1.

Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $2.75 to $1.

Read at benzinga.com